Absorption, metabolism and excretion of [14C]-ABT-510 in healthy subjects.

被引:0
|
作者
Achari, R [1 ]
Aoyama, R [1 ]
Knight, R [1 ]
Humerickhouse, R [1 ]
O'Dea, R [1 ]
机构
[1] Abbott Labs, Abbott Pk, IL 60064 USA
来源
JOURNAL OF CLINICAL PHARMACOLOGY | 2005年 / 45卷 / 09期
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
31
引用
收藏
页码:1074 / 1074
页数:1
相关论文
共 50 条
  • [1] A PHASE I, OPEN-LABEL STUDY OF THE ABSORPTION, METABOLISM, AND EXCRETION OF [14C]-SOTORASIB (AMG 510) IN HEALTHY MALE SUBJECTS.
    Vuu, I.
    Hutton, S.
    Purkis, J.
    Mather, O.
    Dutta, S.
    Houk, B.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 : S49 - S50
  • [2] An evaluation of the absorption, metabolism, and excretion of orally administered [14C]-TR-701 FA in healthy subjects.
    Dreskin, Howard
    Boyea, Teresa
    Barker, Jeff
    Fang, Edward
    Flanagan, Shawn
    Prokocimer, Philippe
    PHARMACOTHERAPY, 2012, 32 (10): : E214 - E214
  • [3] Absorption, Distribution, Metabolism and Excretion of [14C]Dexlansoprazole in Healthy Male Subjects
    Brian Grabowski
    Ronald D. Lee
    Clinical Drug Investigation, 2012, 32 : 319 - 332
  • [4] Absorption, metabolism, excretion, and safety of [14C]almonertinib in healthy Chinese subjects
    Zhou, Chen
    Xie, Lijun
    Liu, Wei
    Zhang, Lingling
    Zhou, Sufeng
    Wang, Lu
    Chen, Juan
    Li, Huan
    Zhao, Yuqing
    Zhu, Bei
    Ding, Sijia
    Zhang, Chen
    Shao, Feng
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (10)
  • [5] Absorption, distribution, metabolism, and excretion of [14C]-labeled naloxegol in healthy subjects
    Bui, Khanh
    She, Fahua
    Hutchison, Michael
    Brunnstrom, Asa
    Sostek, Mark
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2015, 53 (10) : 838 - 846
  • [6] Absorption, Distribution, Metabolism and Excretion of [14C]Dexlansoprazole in Healthy Male Subjects
    Grabowski, Brian
    Lee, Ronald D.
    CLINICAL DRUG INVESTIGATION, 2012, 32 (05) : 319 - 332
  • [7] Pharmacokinetics (PK) of the angiogenesis inhibitor ABT-510 in healthy subjects
    Karyekar, CS
    Carr, RA
    Andre, A
    Wang, Q
    Facey, I
    Marsh, K
    Daszkowski, D
    Humerickhouse, R
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 215S - 215S
  • [8] ABSORPTION DISTRIBUTION METABOLISM AND EXCRETION OF ORAL [14C]-IBREXAFUNGERP IN HEALTHY MALE SUBJECTS
    Azie, N.
    Angulo, D.
    Evans, P.
    Murphy, G.
    Ghahramani, P.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 : S12 - S12
  • [9] Disposition of [14C]etoricoxib in healthy subjects.
    Agrawal, NG
    Geer, LA
    Cui, D
    Halpin, RA
    Matthews, CZ
    Woolf, EJ
    Porras, AG
    Larson, PJ
    Lasseter, KC
    Gottesdiener, KG
    Rodrigues, AD
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (02) : P49 - P49
  • [10] Pharmacokinetics, Metabolism, and Excretion of Intravenous [14C]Difelikefalin in Healthy Subjects and Subjects on Hemodialysis
    Stark, Jeffrey G.
    Noonan, Patrick K.
    Spencer, Robert H.
    Bhaduri, Sarbani
    O'Connor, Stephen J.
    Menzaghi, Frederique
    CLINICAL PHARMACOKINETICS, 2023, 62 (09) : 1231 - 1241